UroGen Pharma Ltd (URGN) — Free Cash Flow Generation Index

Latest as of September 2017: 0.99x

UroGen Pharma Ltd (URGN) has a Free Cash Flow Generation Index of 0.99x as of September 2017. Free cash flow of $2.58 Million represents 1% of operating cash flow ($2.60 Million). See working capital position of UroGen Pharma Ltd to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.99x

Free Cash Flow / Operating CF

Free Cash Flow

$2.58 Million

USD

Operating Cash Flow

$2.60 Million

USD

Capital Expenditures

$20.00K

USD

UroGen Pharma Ltd Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for UroGen Pharma Ltd across 1 annual periods. Explore UroGen Pharma Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for UroGen Pharma Ltd (2016–2016)

Year-by-year Free Cash Flow Generation Index for UroGen Pharma Ltd. For the full company profile including market capitalisation, see market value of UroGen Pharma Ltd.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2016	0.83x	$3.49 Million	$4.19 Million	$695.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).